Search Results - "Hunter‐Schlichting, DeVon"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
  2. 2

    KMT2A‐D pathogenicity, prevalence, and variation according to a population database by Larson, Jenna K., HunterSchlichting, DeVon N., Crowgey, Erin L., Mills, Lauren J., Druley, Todd E., Marcotte, Erin L.

    Published in Cancer medicine (Malden, MA) (01-03-2023)
    “…Introduction The KMT2 family of genes is essential epigenetic regulators promoting gene expression. The gene family contains three subgroups, each with two…”
    Get full text
    Journal Article
  3. 3

    Quantification of low-level human cytomegalovirus and Epstein-Barr virus DNAemia by digital PCR by Hunter-Schlichting, DeVon N., Vogel, Rachel I., Geller, Melissa A., Nelson, Heather H.

    Published in Journal of virological methods (01-04-2024)
    “…Digital PCR (dPCR) can quantify cell-free viral DNA (DNAemia), a biomarker of active viral infection. To accelerate epidemiologic investigation into low-level…”
    Get full text
    Journal Article
  4. 4

    Prevalence of active cytomegalovirus infection at diagnosis of ovarian cancer and during chemotherapy and subsequent changes in cognitive functioning by Vogel, Rachel I, Stenzel, Ashley E, Lee, Heewon, Hunter-Schlichting, DeVon, Wesley, Erin, Uppendahl, Locke D, Geller, Melissa A, Nelson, Heather H

    Published in BMC cancer (03-11-2023)
    “…Purpose One of the most frequently reported effects of cancer and its treatments is cancer-related cognitive impairment (CRCI). Viral infections may affect…”
    Get full text
    Journal Article
  5. 5

    Cytomegalovirus infection in malignant pleural mesothelioma by Hunter-Schlichting, DeVon, Kelsey, Karl T, Demmer, Ryan, Patel, Manish, Bueno, Raphael, Christensen, Brock, Fujioka, Naomi, Kolarseri, Deepa, Nelson, Heather H

    Published in PloS one (12-08-2021)
    “…Human cytomegalovirus (HCMV) is a highly prevalent herpes virus which persists as a latent infection and has been detected in several different tumor types…”
    Get full text
    Journal Article
  6. 6

    Associations of cytomegalovirus infection with cancer-related cognitive impairment and peripheral neuropathy in ovarian cancer survivors by Li, Xuan, Argenta, Peter A., Brown, Katherine, Honeyfield, Kate, Hunter-Schlichting, Devon, Gruner, Morgan, Teoh, Deanna, Peres, Lauren C., Geller, Melissa, Nelson, Heather H., Vogel, Rachel I.

    Published in Gynecologic oncology (01-12-2024)
    “…To assess the associations between active CMV infection and patient-reported symptoms of cancer-related cognitive impairment (CRCI) and peripheral neuropathy…”
    Get full text
    Journal Article
  7. 7

    The effects of cytomegalovirus reactivation and systemic inflammation on adaptive NK cells in ovarian cancer patients by Wesley, Erin, Uppendahl, Locke, Felices, Martin, Messelt, Audrey, Hunter-Schlichting, DeVon, Vogel, Rachel, Nelson, Heather, Geller, Melissa

    Published in Gynecologic oncology (01-08-2021)
    “…Identify if CMV reactivation allows for expansion of a special adaptive (natural killer) NK cell population with enhanced ability to kill ovarian cancer and…”
    Get full text
    Journal Article
  8. 8

    Abstract 614: Cytomegalovirus (CMV) reactivation and patient survival in head and neck cancer by Nelson, Heather H., Miller, Jeffrey S., Hunter-Schlichting, DeVon, Butler, Rondi A., Kelsey, Karl T.

    Published in Cancer research (Chicago, Ill.) (01-07-2019)
    “…There is building evidence that cytomegalovirus (CMV) may contribute to the development of solid tumors, however to date this has not been investigated in head…”
    Get full text
    Journal Article
  9. 9

    Evaluation of adaptive NK cells in ovarian cancer patients with cytomegalovirus (CMV) reactivation and systemic inflammation by Wesley, Erin, Uppendahl, Locke, Felices, Martin, Messelt, Audrey, Hunter-Schlichting, Devon, Nelson, Heather, Bendzick, Laura, Geller, Melissa Ann

    Published in Journal of clinical oncology (20-05-2020)
    “…Abstract only e18062 Background: Cytomegalovirus (CMV) is a common infection associated with increased inflammation (c-reactive protein (CRP) upon reactivation…”
    Get full text
    Journal Article
  10. 10

    Abstract 6374: Socio-demographic predictors of recruitment in neuroblastoma therapeutic clinical trials by Hunter-Schlichting, DeVon, Sample, Jeannette, Knowles, Kate, Van Riper, David, Spector, Logan, Marcotte, Erin

    Published in Cancer research (Chicago, Ill.) (22-03-2024)
    “…The generalizability of clinical trial outcomes hinges upon the equitable access and enrollment of diverse patient populations. Yet, disparities persist that…”
    Get full text
    Journal Article
  11. 11

    Human cytomegalovirus alters immune cell profile with potential implications for patient survival in head and neck cancer by Nelson, Heather H, Contestabile, Emma, Hunter-Schlichting, DeVon, Koestler, Devin, Pawlita, Michael, Waterboer, Tim, Christensen, Brock C, Petersen, Curtis L, Miller, Jeffrey S, Kelsey, Karl T

    Published in Carcinogenesis (New York) (04-06-2022)
    “…Abstract Cytomegalovirus (CMV) is a highly prevalent human herpes virus that exerts a strong influence on immune repertoire which may influence cancer risk. We…”
    Get full text
    Journal Article
  12. 12

    Validation of a hybrid approach to standardize immunophenotyping analysis in large population studies: The Health and Retirement Study by Hunter-Schlichting, DeVon, Lane, John, Cole, Benjamin, Flaten, Zachary, Barcelo, Helene, Ramasubramanian, Ramya, Cassidy, Erin, Faul, Jessica, Crimmins, Eileen, Pankratz, Nathan, Thyagarajan, Bharat

    Published in Scientific reports (29-05-2020)
    “…Traditional manual gating strategies are often time-intensive, place a high burden on the analyzer, and are susceptible to bias between analyzers. Several…”
    Get full text
    Journal Article
  13. 13
  14. 14